Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs

Am J Pathol. 2011 Feb;178(2):599-608. doi: 10.1016/j.ajpath.2010.10.032.

Abstract

Obliteration of the small airways is a largely unresolved challenge in pulmonary medicine. It represents either the irreversible cause of functional impairment or a morphologic disorder of limited importance in a multitude of diseases. Bronchiolitis obliterans is a key complication of lung transplantation. No predictive markers for the onset of obliterative remodeling are currently available. To further elucidate the molecular mechanisms of airway remodeling, compartment-specific expression patterns were analyzed in patients. For this purpose, remodeled and nonremodeled bronchioli were isolated from transplanted and nontransplanted lung explants using laser-assisted microdissection (n = 24). mRNA expression of 45 fibrosis-associated genes was measured using quantitative real-time RT-PCR. For 20 genes, protein expression was also analyzed by immunohistochemistry. Infiltrating cells were characterized at conventional histology and immunohistochemistry. Obliterative remodeling of the small airways in transplanted and nontransplanted lungs shared similar grades of chronic inflammation and pivotal fibrotic pathways such as transforming growth factor β signaling and increased collagen expression. Bone morphogenetic protein and thrombospondin signaling, and also matrix metalloproteinases and tissue inhibitor of metalloproteinases, were primarily up-regulated in obliterative airway remodeling in nontransplanted lungs. In transplanted lungs, clinical remodeled bone morphogenetic protein but nonremodeled bronchioli were characterized by a concordant up-regulation of matrix metalloproteinase-9, RANTES, and tissue inhibitor of metalloproteinase-1. These distinct expression patterns warrant further investigation as potential markers of impending airway remodeling, especially for prospective longitudinal molecular profiling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Airway Remodeling / genetics
  • Airway Remodeling / physiology*
  • Biomarkers / metabolism
  • Biopsy
  • Bronchioles / pathology
  • Bronchioles / physiopathology
  • Bronchiolitis Obliterans / enzymology
  • Bronchiolitis Obliterans / genetics
  • Bronchiolitis Obliterans / physiopathology*
  • Chemokine CCL5 / genetics
  • Chemokine CCL5 / metabolism
  • Gene Expression Regulation
  • Humans
  • Immunohistochemistry
  • Lung / metabolism*
  • Lung / pathology
  • Lung / physiopathology*
  • Lung Transplantation*
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Signal Transduction*
  • Smad Proteins / metabolism
  • Tissue Inhibitor of Metalloproteinase-1 / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism

Substances

  • Biomarkers
  • CCL5 protein, human
  • Chemokine CCL5
  • RNA, Messenger
  • Smad Proteins
  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinase 9